|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 797.00 USD | -1.37% |
|
+4.78% | +3.26% |
| Market Cap | 7.96TCr 6.9TCr 6.46TCr 5.89TCr 11TCr 7,59100Cr 11TCr 76TCr 30TCr 3,79900Cr 30TCr 29TCr 12,67500Cr | P/E 2026 * |
18.8x | P/E 2027 * | 15.8x |
|---|---|---|---|---|---|
| Enterprise Value | 7.27TCr 6.3TCr 5.9TCr 5.38TCr 10TCr 6,93600Cr 10TCr 69TCr 27TCr 3,47100Cr 27TCr 27TCr 11,58100Cr | EV / Sales 2026 * |
4.31x | EV / Sales 2027 * | 3.76x |
| Free-Float |
71.07% | Yield 2026 * |
0.49% | Yield 2027 * | 0.56% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -1.37% | ||
| 1 week | +4.78% | ||
| Current month | +4.51% | ||
| 1 month | +19.94% | ||
| 3 months | +11.82% | ||
| 6 months | +2.31% | ||
| Current year | +3.26% |
| 1 week | 762.78 |  | 813.63 |
| 1 month | 637.8 | | 813.63 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/07/26 | Sell | Director | -200 | 0.0002% | ||
| 19/02/26 | Fiscal year | Director | 4,914 | 0.0048% | ||
| 09/02/26 | Fiscal year | SVP Controller | 4,036 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.37% | +4.78% | +45.99% | -1.23% | 7.96TCr | |
| +2.55% | +9.01% | +1.40% | +30.65% | 5.27TCr | |
| -0.84% | -2.14% | +19.91% | +173.07% | 4.98TCr | |
| +0.08% | +5.95% | -47.62% | -47.36% | 4.68TCr | |
| -1.56% | -2.19% | +59.29% | -25.50% | 3.01TCr | |
| -0.39% | +0.39% | +52.89% | +83.63% | 2.45TCr | |
| +1.27% | +6.28% | +137.81% | -40.32% | 2.42TCr | |
| 0.00% | +5.81% | +9.45% | +194.91% | 2.12TCr | |
| -1.15% | +1.99% | +73.51% | +169.39% | 1.64TCr | |
| -5.89% | +22.69% | -0.99% | +796.32% | 1.61TCr | |
| Average | -0.73% | +173.34% | +35.16% | +133.36% | 3.61TCr | |
| Weighted average by Cap. | -0.42% | +261.96% | +28.50% | +77.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.69TCr 1.46TCr 1.37TCr 1.25TCr 2.35TCr 1,61100Cr 2.39TCr 16TCr 6.29TCr 81TCr 6.34TCr 6.2TCr 2,69000Cr | 1.83TCr 1.59TCr 1.49TCr 1.36TCr 2.55TCr 1,74900Cr 2.6TCr 17TCr 6.84TCr 88TCr 6.89TCr 6.74TCr 2,92100Cr |
| Net income | 460.64Cr 399.19Cr 373.7Cr 340.98Cr 641.66Cr 44TCr 652.44Cr 4.38TCr 1.72TCr 22TCr 1.73TCr 1.69TCr 73TCr | 535.26Cr 463.85Cr 434.24Cr 396.22Cr 745.61Cr 51TCr 758.14Cr 5.09TCr 1.99TCr 26TCr 2.01TCr 1.97TCr 85TCr |
| Net Debt | -686.84Cr -595.21Cr -557.22Cr -508.42Cr -956.76Cr -66TCr -972.84Cr -6.53TCr -2.56TCr -33TCr -2.58TCr -2.52TCr -1,09400Cr | -1.06TCr -914.59Cr -856.21Cr -781.24Cr -1.47TCr -1,00700Cr -1.49TCr -10TCr -3.93TCr -50TCr -3.96TCr -3.88TCr -1,68100Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $797.00 | -1.37% | 9,39,190 |
| 10/26/10 | $808.05 | +3.02% | 12,13,798 |
| 07/26/07 | $784.36 | +1.59% | 8,37,598 |
| 06/26/06 | $772.11 | +0.46% | 7,83,950 |
| 05/26/05 | $768.58 | +1.04% | 5,32,482 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
